Authors
Loading...
Review highlights stimuli-responsive biomaterials to improve drug delivery in melanoma, addressing treatment challenges.
Chitakunye et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: